Patent · US Active

Antibodies to CD70

US11072665B2 · kind B2 · utility

2Cited by

28References

39Claims

0Family size

Assignee

argenx BVBA · BE

Inventors

Karen Silence · Overijse, BE
Peter Ulrichts · Breda, NL
Johannes Joseph Wilhelmus De Haard · Vlaardingen, NL
Torsten Dreier · Breda, NL
Michael John Scott Saunders · Wondelgem, BE
Harald Wajant · Echterdingen, DE
Sofie Maria Elvire Gabriels · Zottegem, BE
Mahan Moshir · Oostakker, BE

Key dates

Filing date	Feb 19, 2015
Grant date	Jul 27, 2021
Priority date	—
Expiry date	Jul 4, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/94
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to antibodies and antigen binding fragments thereof which bind to the human CD70 protein with high affinity and display potent inhibition of tumor cell growth.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.